Ronen Eavri

• Dual Machine Learning-Driven Optimization: Barcode Nanotech integrates two specialized machine learning models, one for lipid design and another for nanoparticle formulation, to systematically optimize RNA delivery vehicles. This approach enables precise tailoring of LNPs to target specific cell types across diverse tissues, enhancing therapeutic efficacy and reducing off-target effects
• High-Throughput In Vivo Screening with DNA Barcoding: Using a proprietary DNA barcode system, Barcode Nanotech can simultaneously test up to 100 LNP formulations in a single animal. Each formulation is uniquely tagged, allowing for accurate quantification of delivery efficiency across multiple organs and cell types, accelerating discovery and validation
• Data-Driven Formulation and Structure Insights: The platform generates rich, multidimensional datasets that link lipid chemistry, nanoparticle architecture, and biological performance. These result in iterative design cycles, enabling the refinement of both lipid structures and nanoparticle formulations to achieve optimal RNA delivery profiles

NEW COMPANY